Studies have explored CD5-CAR-NK cells (68) and CD7-CAR-NK cells (69) for T-cell acute lymphoblastic leukemia (T-ALL) treatment and FLT3-CAR-NK cells in B-cell acute lymphoblastic leukemia (B-ALL) (70). Here, FLT3 is linked to acute lymphoblastic leukemia.